An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.

Researchers have rapidly identified ways to apply their expertise to help end the pandemic.

A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.

The agency cites lapses in biosafety procedures at the US Army Medical Research Institute of Infectious Diseases in Maryland.

Two professors have been arrested for negligence in connection with the blast.

Only a few labs will earn funding for such “gain-of-function” research on SARS, MERS, and other deadly diseases.

Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release. 

After a string of breaches involving anthrax, Ebola, and bird flu, the US Centers for Disease Control and Prevention has reportedly replaced the director of its Division of Select Agents and Toxins.

“Kill switches” ensure that genetically engineered bacteria survive only in certain environmental conditions.